关键词: Biosecurity CRISPR-Cas system Disinfectant resistance Mobile genetic elements Multidrug resistance

Mesh : Animals Anti-Bacterial Agents / pharmacology therapeutic use Bacteria / drug effects genetics Bacterial Infections / drug therapy genetics CRISPR-Cas Systems / genetics Disinfectants / pharmacology therapeutic use Drug Resistance, Multiple, Bacterial / genetics Humans

来  源:   DOI:10.1016/j.drup.2019.100672   PDF(Sci-hub)

Abstract:
Antibiotic resistance could accelerate humanity towards an already fast-approaching post-antibiotic era, where disinfectants and effective biosecurity measures will be critically important to control microbial diseases. Disinfectant resistance has the potential to change our way of life from compromising food security to threatening our medical health systems. Resistance to antimicrobial agents occurs through either intrinsic or acquired resistance mechanisms. Acquired resistance occurs through the efficient transfer of mobile genetic elements, which can carry single, or multiple resistance determinants. Drug resistance genes may form part of integrons, transposons and insertions sequences which are capable of intracellular transfer onto plasmids or gene cassettes. Thereafter, resistance plasmids and gene cassettes mobilize by self-transmission between bacteria, increasing the prevalence of drug resistance determinants in a bacterial population. An accumulation of drug resistance genes through these mechanisms gives rise to multidrug resistant (MDR) bacteria. The study of this mobility is integral to safeguard current antibiotics, disinfectants and other antimicrobials. Literature evidence, however, indicates that knowledge regarding disinfectant resistance is severly limited. Genome engineering such as the CRISPR-Cas system, has identified disinfectant resistance genes, and reversed resistance altogether in certain prokaryotes. Demonstrating that these techniques could prove invaluable in the combat against disinfectant resistance by uncovering the secrets of MDR bacteria.
摘要:
暂无翻译
公众号